Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 9/20 | 0.50 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.48 |
| ▸ | ITGA5 | P08648 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.45 |
| ▸ | ESR1 | P03372 | 1/20 | 0.45 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.45 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.45 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | GGT1 | P19440 | 1/20 | 0.45 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.45 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.45 |
| ▸ | BLM | P54132 | 1/20 | 0.45 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 3/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30084385 | 0.98 | TSHR (0.52) | TSHRITGB1ITGA5ALDH1A1HSD17B10 | |
| SCHEMBL2778 | 0.98 | TSHR (0.52) | TSHRITGB1ITGA5ALDH1A1HSD17B10 | |
| SCHEMBL27931437 | 0.95 | TSHR (0.50) | TSHRITGB1ITGA5ALDH1A1HSD17B10 | |
| Acetone SCHEMBL29281281 | 0.95 | TSHR (0.50) | TSHRITGB1ITGA5ALDH1A1HSD17B10 | |
| SCHEMBL28206063 | 0.95 | TSHR (0.50) | TSHRITGB1ITGA5ALDH1A1HSD17B10 | |
| SCHEMBL6383298 | 0.95 | TSHR (0.50) | TSHRITGB1ITGA5ALDH1A1HSD17B10 | |
| Acetic Acid SCHEMBL28536661 | 0.93 | TSHR (0.48) | TSHRITGB1ITGA5ALDH1A1HSD17B10 | |
| SCHEMBL27748399 | 0.92 | ALDH1A1 (0.56) | TSHRITGB1ITGA5ALDH1A1HSD17B10 | |
| SCHEMBL5006514 | 0.91 | TSHR (0.47) | TSHRITGB1ITGA5ALDH1A1HSD17B10 | |
| SCHEMBL154741 | 0.89 | ALDH1A1 (0.58) | TSHRITGB1ITGA5ALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114727950-A | 1- (((2S,3S,4S) -3-ethyl-4-fluoro-5-oxopyrrolidin-2-yl) methoxy) -7-methoxyisoquinoline-6-carboxamide combinations and oral dosage forms | 辉瑞大药厂 | 2022-07-08 | — | — | CN | disclosed |
| CN-105101952-B | Oral sustained release formulation of tofacitinib | 辉瑞公司 | 2022-06-28 | — | — | CN | disclosed |
| CN-107567440-B | Pyroglutamic acid vortioxetine | H.隆德贝克有限公司 | 2021-06-22 | — | — | CN | disclosed |
| CN-112741816-A | Novel colon drug delivery system | 江苏集萃新型药物制剂技术研究所有限公司 | 2021-05-04 | — | — | CN | disclosed |
| CN-112739222-A | Anti-aging agent and anti-aging method | 田中惠 | 2021-04-30 | — | — | CN | disclosed |
| CN-111939154-A | Anti-aging composition, application thereof, and health food and medicine containing anti-aging composition | 周琛 | 2020-11-17 | — | — | CN | disclosed |
| CN-111419817-A | Oral sustained release formulation of tofacitinib | 辉瑞公司 | 2020-07-17 | — | — | CN | disclosed |
| CN-111093397-A | Anti-aging agent and anti-aging method | 田中惠 | 2020-05-01 | — | — | CN | disclosed |
| CN-101400358-B | Scf extract containing cardiac glycoside | PHOENIX BIOTECHNOLOGY INC | 2013-06-05 | — | — | CN | disclosed |
| CN-102172363-B | SCF extract containing cardiac glycoside | PHOENIX BIOTECHNOLOGY INC | 2013-04-24 | — | — | CN | disclosed |
| CN-102172363-A | Scf extract containing cardiac glycoside | PHOENIX BIOTECHNOLOGY INC | 2011-09-07 | — | — | CN | disclosed |
| WO-2011060944-A2 | ACTIVE PHARMACEUTICAL INGREDIENT CAPSULES AND POLYUNSATURATED FATTY ACID ESTERS | GP PHARM, S.A. (ES) | 2011-05-26 | — | — | WO | disclosed |
| CN-100486568-C | Loxoprofen sodium sustained release preparation | UNIV FUDAN (CN) | 2009-05-13 | — | — | CN | disclosed |
| CN-101400358-A | SCF extract containing cardiac glycoside | PHOENIX BIOTECHNOLOGY INC (US) | 2009-04-01 | — | — | CN | disclosed |
| CN-101132781-A | Room-temperature stable dronabinol formulations | INSYS THERAPEUTICS INC (US) | 2008-02-27 | — | — | CN | disclosed |
| CN-1901888-A | Pharmaceutical compositions comprising lercanidipine | LIFECYCLE PHARMA AS (DK) | 2007-01-24 | — | — | CN | disclosed |
| CN-1628648-A | Loxoprofen sodium sustained release preparation | UNIV FUDAN (CN) | 2005-06-22 | — | — | CN | disclosed |